Crescent Capital BDC logo

Crescent Capital BDC(NASDAQ) CCAP

Market Cap$365.51MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2020)+29%
5 Year-5%
1 Year-29%
1 Month-10%
Premium Feature
Moneyball Superscore
47/100
$9.93
+0.00%
+0.00Today
After hours$9.93-$0.00 (-0.05%)
Crescent Capital BDC last closing stock price
MetricPriceDate
Last closeUSD 9.922026-09-11
Crescent Capital BDC stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-4.34%USD 10.372026-09-04
1 month-10.21%USD 11.052026-08-12
3 month-8.89%USD 10.892026-06-12
Year to date-24.22%USD 13.092025-12-31
1 year-28.69%USD 13.912025-09-11
3 year-13.63%USD 11.482023-09-12
5 year-5.39%USD 10.482021-09-10
Since inception+29.19%USD 7.682020-02-03

Crescent Capital BDC Financials at a Glance

Market Cap

$365.51MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$112.73M

Net Income (TTM)

-$3.17M

EPS (TTM)

-$0.09

P/E Ratio

-113.89

Dividend

$1.60

Beta (Volatility)

0.53 (Low)

Price

$9.93

Volume

259,123.062

Open

$9.94

Previous Close

$9.92

Daily Range

$9.89 - $10.03

52-Week Range

$9.88 - $15.73

Estimated Earnings Date

Nov 11, 2026

CCAP News

CCAP: Motley Fool Moneyball Superscore

47

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Crescent Capital BDC

Crescent Capital lends money to medium-sized American businesses to help them grow. It acts like a bank for companies too small for big markets. These loans help businesses fund their daily operations and expansion plans.

What Does Crescent Invest In?

  • Senior Secured Loans: Debt backed by the borrower's assets that gets paid back first; these form the core of the portfolio.
  • Unitranche Financing: Specialized loans that combine multiple types of debt into one package for medium-sized companies.
  • Equity Investments: Ownership stakes in companies through common or preferred stock to gain from their long-term growth.
  • Revolving Credit: Flexible lines of credit that businesses can draw from as they need cash for operations.

Strategic Moves and Partnerships

  • Invested in Patriot Growth Insurance Services through a mix of revolver and unitranche loan commitments.
  • Provided unitranche first lien term loans to Team Select to support its operations in health care equipment.
  • Expanded the portfolio with debt and equity investments in Hospice Care Buyer within the medical services sector.
  • Funded software and services through unitranche term loans for companies like Net Health Acquisition Corp.

Why the Business Model Works

Crescent focuses on the United States middle market by providing tailored financing to companies in stable sectors like healthcare and software. The firm uses its expertise in debt structuring to manage risk while supporting businesses owned by private equity firms.

Recent Financial Performance

  • Revenue reached $43.9 million in Q4 2025, up 65.7% year-over-year.
  • Gross profit hit $35.4 million in Q4 2025, up 186% from $12.4 million in Q4 2024.
  • Operating income hit $47.9 million in Q4 2025, up 374.3% from the previous year.
  • Net income was $8.5 million in Q4 2025, down 15% from $10 million in Q4 2024.

The Final Word

Crescent has evolved by diversifying its portfolio across multiple debt instruments to provide steady returns from the American middle market. Its ability to structure complex loans allows it to adapt to the changing financial needs of private companies.

AI Generated • May 5, 2026

Industry

Capital Markets

Employees

0

CEO

Jason A. Breaux, MBA

Headquarters

Los Angeles, CA 90025, US

CCAP Financials

Key Financial Metrics (TTM)

Gross Margin

69.61%

Operating Margin

58.43%

Net Income Margin

-2.81%

Return on Equity

-0.46%

Return on Capital

7.53%

Return on Assets

-0.20%

Earnings Yield

-0.88%

Dividend Yield

16.05%

Payout Ratio

-25.46%

Stock Overview

Market Cap

$365.51MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

36.85M

Volume

259.12K

Avg. Volume

258.44K

Financials (TTM)

Gross Profit

$78.47M

Operating Income

$65.86M

EBITDA

$47.93M

Operating Cash Flow

$58.36M

Capital Expenditure

$0.00

Free Cash Flow

$58.36M

Cash & ST Invst.

$15.60M

Total Debt

$922.95M

Crescent Capital BDC Performance Analysis

Crescent Capital BDC annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 121,695,000-3.6%
20232023-12-31USD 172,690,00041.9%
20242024-12-31USD 194,846,00012.8%
20252025-12-31USD 156,186,000-19.8%
Crescent Capital BDC sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-29.7%
Q42025-12-3192.6%
Q12026-03-31-41.7%
Q22026-06-30-20.3%
Crescent Capital BDC annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD 0.50-82.9%
20232023-12-31USD 2.33363.7%
20242024-12-31USD 1.99-14.8%
20252025-12-31USD 0.93-53.1%
Crescent Capital BDC sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-53.7%
Q42025-12-3121.1%
Q12026-03-31-282.6%
Q22026-06-3078.6%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$20.40M

-37.1%

Gross Profit

$14.15M

-26.1%

Gross Margin

69.37%

N/A

Market Cap

$365.51MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$1.46M

N/A

Employees

250

N/A

Net Income

-$3.25M

-121.6%

EBITDA

$12.32M

-20.1%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$15.60M

+60.2%

Total Debt

$922.95M

+4.0%

Accounts Receivable

$8.21M

-66.2%

Inventory

$0.00

N/A

Long Term Debt

$922.95M

+4.0%

Short Term Debt

$0.00

N/A

Return on Assets

-0.20%

N/A

Return on Invested Capital

4.12%

N/A

Free Cash Flow

$28.75M

-21.1%

Operating Cash Flow

$28.75M

-21.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CIONCION Investment Corporation
$7.18+1.41%
TCPCBlackRock TCP Capital Corp.
$4.07+1.50%
MCIBarings Corporate Investors
$19.54+1.40%
GLADGladstone Capital Corporation
$19.48+0.52%

Trending Stocks

Symbol / CompanyPricePrice Chg
KHCKraft Heinz
$24.60+0.01%
ACVAACV Auctions
$10.41+0.44%
TNONTenon Medical
$5.93+0.12%
ETHAiShares Ethereum Trust - iShares Ethereum Trust ETF
$19.16+0.03%

Questions About CCAP

What is the current price of Crescent Capital BDC?

Crescent Capital BDC is trading at $9.92 per share.

What is the 52-week range for Crescent Capital BDC?

Over the past 52 weeks, Crescent Capital BDC has traded between $9.88 and $15.73.

How much debt does Crescent Capital BDC have?

As of the most recent reporting period, Crescent Capital BDC reported total debt of $922.95M.

How much cash does Crescent Capital BDC have on hand?

Crescent Capital BDC reported $35.74M in cash and cash equivalents in its most recent financial results.

What is Crescent Capital BDC’s dividend yield?

Crescent Capital BDC currently has a dividend yield of 16.05%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.